Reflecting on Treatment Strategies for Acute Leukemia
War starts only after its strategist maps out where the enemy is obvious and where it can hide. This is the strategy of every oncologist planning assault on cancer. Every cancer, except acute leukemia....
View ArticleWe Can Treat Hodgkin’s Lymphoma Like Melanoma?
The news that agents effective in melanoma, renal cell, and non-small cell lung cancers can achieve complete remissions in heavily pretreated, mainly nodular sclerosis, Hodgkin’s lymphoma1 should...
View ArticleIsabel Cunningham Holds CML Question-and-Answer Session With Jane Apperley, MD
Professor Jane Apperley, MD, is chair of the Centre for Haematology at Imperial College London, Department of Medicine. She is considered one of the most distinguished global hematology experts. Her...
View ArticleAge and Acute Myeloid Leukemia: A Review of Current Literature
Many doctors who treat leukemia are perplexed about the designation of patients as “elderly” at age 60 or 65. This is not infrequently the age of their doctor, who might not like to imagine himself or...
View ArticleA Glimpse of ASH
Choosing several abstracts to highlight among hundreds of interesting presentations on hematologic malignancies from the American Society of Hematology (ASH) annual meeting is a difficult task. Some...
View ArticleIsn’t Leukemia Still Cancer?
Leukemia was separated from other cancers in the late 1960s, when effective drugs started to return some leukemic marrows to normal, and patients to normal lives — if only temporarily. No similarly...
View Article
More Pages to Explore .....